Related Experiment Video
Updated: Jul 4, 2025

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
Published on: May 6, 2014
CircLZIC regulates ox-LDL-induced HUVEC cell proliferation and apoptosis via Micro-330-5p/NOTCH2 axis in
Xingping Men1, Aizhen Hu1, Tingting Xu1
1Department of Cardiology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong, China.
Insights
Circular RNA LZIC (circLZIC) promotes atherosclerosis by inhibiting MicroRNA-330-5p, leading to increased NOTCH2 expression and HUVEC cell proliferation, while suppressing apoptosis. This highlights circLZIC as a key regulator in atherosclerosis development.
Area of Science:
- Cardiovascular Biology
- Molecular Biology
- Epigenetics
Background:
- Atherosclerosis (AS) is a leading cause of cardiovascular disease, driven by chronic inflammation.
- Circular RNAs (circRNAs) are emerging as critical epigenetic regulators of vascular inflammation and AS progression.
- Understanding circRNAs that modulate ox-LDL levels is crucial for deciphering AS pathology.
Purpose of the Study:
- To investigate the role of circLZIC in regulating atherosclerosis (AS) through the MicroRNA-330-5p/NOTCH2 axis.
- To elucidate the molecular mechanisms by which circLZIC influences human umbilical vein endothelial cell (HUVEC) behavior in the context of AS.
Main Methods:
- Analysis of circLZIC, MicroRNA-330-5p, and NOTCH2 expression in human AS samples.
- Cell proliferation (CCK-8) and apoptosis (flow cytometry) assays in HUVECs.
- RNA interference, dual-luciferase reporter assays, and RIP-qRT-PCR to confirm regulatory interactions.
Main Results:
- CircLZIC and NOTCH2 were highly expressed in AS samples, while MicroRNA-330-5p was locally expressed.
- CircLZIC promoted HUVEC proliferation and inhibited apoptosis; its knockdown increased MicroRNA-330-5p, promoted apoptosis, and inhibited NOTCH2.
- MicroRNA-330-5p targeted NOTCH2, and its overexpression reduced NOTCH2 expression, inhibited apoptosis, and decreased cell activity.
Conclusions:
- CircLZIC promotes HUVEC proliferation and inhibits apoptosis via the MicroRNA-330-5p/NOTCH2 pathway.
- CircLZIC plays a significant role in the development of atherosclerosis.
- The circLZIC/MicroRNA-330-5p/NOTCH2 axis represents a potential therapeutic target for AS.
Abstract:
Atherosclerosis (AS) is a major chronic non-communicable disease and a primary cause of cardiovascular disease. Recent studies have shown that circRNAs are potential epigenetic factors that regulate vascular endothelial inflammatory responses and AS progression. Therefore, identification of the circRNAs that regulate ox-LDL levels is a critical step to understanding the pathology of AS. Our study is aim to investigate how circLZIC regulates atherosclerosis (AS) via the Micro-330-5p/NOTCH2 regulatory axis. The results showed that CircLZIC and NOTCH2 are highly expressed in human AS clinical samples, while Micro-330-5p is expressed locally. The CCK-8 experiment results showed that circLZIC promotes the proliferation of HUVECS cells. Flow cytometry analysis showed that circLZIC act as an inhibitor of HUVEC cell apoptosis. The expression level of Micro-330-5p can be up-regulated by transfection of small interfering RNA against circLZIC. Further, Starbase predicted that Micro-330-5p could target and regulate NOTCH2. Next, we confirmed that overexpression of Micro-330-5p could significantly reduce the expression of fluorescein using the double Luciferase reporter assay. RIP-qRT-PCR experiment showed that Micro-330-5p and NOTCH2 mRNAs are effectively enriched by ago2 protein. Further, we found that knocking down circLZIC increases the expression of Micro-330-5p and promotes cell apoptosis, while inhibiting the expression of NOTCH2 and cell activity. On the other hand, co-transfection of Micro-330-5p inhibitor decreases Micro-330-5p expression and inhibit cell apoptosis, while increasing NOTCH2 expression and cell activity. In conclusion, CircLZIC regulates HUVEC cell activity by the Micro-330-5p/NOTCH2 signaling pathway, suggesting that circLZIC plays a key role in atherosclerosis development.
More Related Videos
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Hedgehog Signaling Pathway
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Inflammation
Regulation of Hematopoietic Stem Cells

